Health / Medical Topics

    Insulin-Like Growth Factor-Binding Protein 5

    IGFBP5 contains a thyroglobulin type-I domain and belongs to the IGFBP family. IGFBPs display strong sequence homologies. IGFBPs contain three distinct domains. N-terminal domain 1 and C-terminal domain 3 contain invariant cysteine residues and are thought to be the IGF binding domains. Domain 2 generally lacks sequence identity among the IGFBPs. Domain 3 is homologous to the thyroglobulin type I repeat. IGF-I and IGF-II circulate in plasma tightly bound to IGFBPs. IGFs, IGFRs, and IGFBPs regulate cell proliferation and apoptosis; the primary effect of IGFBPs appears to be modulation of IGF activity and control of IGF-mediated cell growth and metabolism. Secreted IGF-binding proteins prolong the half-life of IGFs (somatomedins) and either inhibit or stimulate the growth promoting effects of IGFs; they alter the interaction of IGFs with cell surface receptors. (from OMIM 146734, SWISS-PROT P22692, and NCI) (NCI Thesaurus)




    YOU MAY ALSO LIKE

    Insulin-like growth factor-binding protein 3 (291 aa, 32 kD) is a cell fate protein that is encoded by the human IGFBP3 gene…
    Encoded by human IGFBP2 Gene, cysteine-rich high molecular weight secreted 328-aa 35-kD Insulin-Like Growth Factor-Binding Protein 2 precursor contains an IGFBP domain…
    A family of soluble proteins that bind insulin-like growth factors and modulate their biological actions at the cellular level. Serum IGFBP…
    A protein found on the surface of some types of cells that binds to insulin-like growth factor (IGF). This causes the cells…
    Insulin-like growth factor binding protein 4 (258 aa, 28 kD) is a cellular division process protein that is encoded by the human…
    The determination of the amount of insulin-like growth factor binding protein 3 present in a sample.

    © 1991-2023 The Titi Tudorancea Bulletin | Titi Tudorancea® is a Registered Trademark | Terms of use and privacy policy
    Contact